151 related articles for article (PubMed ID: 25040454)
1. Who is using long-acting reversible contraceptive methods? Findings from nine low-fertility countries.
Eeckhaut MC; Sweeney MM; Gipson JD
Perspect Sex Reprod Health; 2014 Sep; 46(3):149-55. PubMed ID: 25040454
[TBL] [Abstract][Full Text] [Related]
2. Contraceptive use in Latin America and the Caribbean with a focus on long-acting reversible contraceptives: prevalence and inequalities in 23 countries.
Ponce de Leon RG; Ewerling F; Serruya SJ; Silveira MF; Sanhueza A; Moazzam A; Becerra-Posada F; Coll CVN; Hellwig F; Victora CG; Barros AJD
Lancet Glob Health; 2019 Feb; 7(2):e227-e235. PubMed ID: 30683240
[TBL] [Abstract][Full Text] [Related]
3. Changes in Use of Long-Acting Reversible Contraceptive Methods Among U.S. Women, 2009-2012.
Kavanaugh ML; Jerman J; Finer LB
Obstet Gynecol; 2015 Nov; 126(5):917-927. PubMed ID: 26444110
[TBL] [Abstract][Full Text] [Related]
4. Choice of contraceptive modality by women in Norway.
Skjeldestad FE
Acta Obstet Gynecol Scand; 1994 Jan; 73(1):48-52. PubMed ID: 8304025
[TBL] [Abstract][Full Text] [Related]
5. Changes in use of long-acting contraceptive methods in the United States, 2007-2009.
Finer LB; Jerman J; Kavanaugh ML
Fertil Steril; 2012 Oct; 98(4):893-7. PubMed ID: 22795639
[TBL] [Abstract][Full Text] [Related]
6. Changes in the Use of Long-Acting Reversible Contraceptive Methods Among U.S. Nulliparous Women: Results from the 2006-2010, 2011-2013, and 2013-2015 National Survey of Family Growth.
Ihongbe TO; Masho SW
J Womens Health (Larchmt); 2018 Mar; 27(3):245-252. PubMed ID: 29148890
[TBL] [Abstract][Full Text] [Related]
7. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
Chiles DP; Roberts TA; Klein DA
Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
[TBL] [Abstract][Full Text] [Related]
8. Postpartum contraceptive use among women with a recent preterm birth.
Robbins CL; Farr SL; Zapata LB; D'Angelo DV; Callaghan WM
Am J Obstet Gynecol; 2015 Oct; 213(4):508.e1-9. PubMed ID: 26003062
[TBL] [Abstract][Full Text] [Related]
9. Changes in the use of effective and long-acting reversible contraception in Vietnam.
Asad S; Hebert C; Andridge R; Nguyen N; Gallo MF
Contraception; 2019 Mar; 99(3):165-169. PubMed ID: 30503505
[TBL] [Abstract][Full Text] [Related]
10. "I don't know enough to feel comfortable using them:" Women's knowledge of and perceived barriers to long-acting reversible contraceptives on a college campus.
Hall KS; Ela E; Zochowski MK; Caldwell A; Moniz M; McAndrew L; Steel M; Challa S; Dalton VK; Ernst S
Contraception; 2016 Jun; 93(6):556-64. PubMed ID: 26879627
[TBL] [Abstract][Full Text] [Related]
11. Game change in Colorado: widespread use of long-acting reversible contraceptives and rapid decline in births among young, low-income women.
Ricketts S; Klingler G; Schwalberg R
Perspect Sex Reprod Health; 2014 Sep; 46(3):125-32. PubMed ID: 24961366
[TBL] [Abstract][Full Text] [Related]
12. Long-acting reversible contraception: Findings from the Understanding Fertility Management in Contemporary Australia survey.
Holton S; Rowe H; Kirkman M; Jordan L; McNamee K; Bayly C; McBain J; Sinnott V; Fisher J
Eur J Contracept Reprod Health Care; 2016; 21(2):116-31. PubMed ID: 26043118
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with utilization of long acting and permanent contraceptive methods among married women of reproductive age in Mekelle town, Tigray region, north Ethiopia.
Alemayehu M; Belachew T; Tilahun T
BMC Pregnancy Childbirth; 2012 Jan; 12():6. PubMed ID: 22280163
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of women in the United States who use long-acting reversible contraceptive methods.
Kavanaugh ML; Jerman J; Hubacher D; Kost K; Finer LB
Obstet Gynecol; 2011 Jun; 117(6):1349-1357. PubMed ID: 21606745
[TBL] [Abstract][Full Text] [Related]
15. Satisfaction, early removal, and side effects associated with long-acting reversible contraception.
Dickerson LM; Diaz VA; Jordon J; Davis E; Chirina S; Goddard JA; Carr KB; Carek PJ
Fam Med; 2013; 45(10):701-7. PubMed ID: 24347187
[TBL] [Abstract][Full Text] [Related]
16. Trends in long-acting reversible contraception use among U.S. women aged 15-44.
Branum AM; Jones J
NCHS Data Brief; 2015 Feb; (188):1-8. PubMed ID: 25714042
[TBL] [Abstract][Full Text] [Related]
17. Free-of-charge long-acting reversible contraception: two-year discontinuation, its risk factors, and reasons.
Saloranta TH; Gyllenberg FK; But A; Gissler M; Laine MK; Heikinheimo O
Am J Obstet Gynecol; 2020 Dec; 223(6):886.e1-886.e17. PubMed ID: 32562657
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of users of intrauterine devices and other reversible contraceptive methods in the United States.
Xu X; Macaluso M; Frost J; Anderson JE; Curtis K; Grosse SD
Fertil Steril; 2011 Nov; 96(5):1138-44. PubMed ID: 21917255
[TBL] [Abstract][Full Text] [Related]
19. Demand for long acting and permanent contraceptive methods and associated factors among married women of reproductive age group in Debre Markos Town, North West Ethiopia.
Bulto GA; Zewdie TA; Beyen TK
BMC Womens Health; 2014 Mar; 14(1):46. PubMed ID: 24625360
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy Ambivalence and Long-Acting Reversible Contraceptive (LARC) Use Among Young Adult Women: A Qualitative Study.
Higgins JA
Perspect Sex Reprod Health; 2017 Sep; 49(3):149-156. PubMed ID: 28419700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
